Cited by 457PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerAutophagy in Disease and Therapy

Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway

Open access
Saxton, Robert A., Knockenhauer, Kevin E., Wolfson, Rachel L., Chantranupong, Lynne, Pacold, Michael E., Wang, Tim, Schwartz, Thomas U., Sabatini, David M.·2016·Science

Abstract

From sensing leucine to metabolic control: The mTORC1 protein kinase complex plays central roles in regulating cell growth and metabolism and is implicated in common human diseases such as diabetes and cancer. The level of the amino acid leucine tells an organism a lot about its physiological state, including how much food is available, how much insulin is going to be needed, and whether new muscle mass can be made (see the Perspective by Buel and Blenis). Wolfson et al. identified a biochemical sensor of leucine, Sestrin2, which connects the concentration of leucine to the control of organismal metabolism and growth. When leucine bound to Sestrin2, it was released from a complex with the mTORC1 regulatory factor GATOR2, activating the mTORC1 complex. Saxton et al. describe the crystal structure of Sestrin2 and show how it specifically detects leucine. Aylett et al. determined the structure of human mTORC1 by cryoelectron microscopy and the crystal structure of a regulatory subunit, Raptor. The results reveal the structural basis for the function and intricate regulation of this important enzyme, which is also a strategic drug target. Science , this issue p. 43 , p. 48 , p. 53 ; see also p. 25

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.aad2087

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Saxton, R. A., Knockenhauer, K. E., Wolfson, R. L., Chantranupong, L., Pacold, M. E., Wang, T., Schwartz, T. U., & Sabatini, D. M.
Affiliations
  • Broad Institute (US)
  • Massachusetts Institute of Technology (US)
Corresponding author
Sabatini, David M.
Venue
Science
Published
2016-01
Volume
351
Issue
6268
Pages
53-58
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2231368253
Cited by
457
References
46
Citations by year
2026: 34 · 2025: 39 · 2024: 36 · 2023: 47 · 2022: 42 · 2021: 52 · 2020: 57 · 2019: 37 · 2018: 43 · 2017: 33 · 2016: 36 · 2015: 1
FWCI
16.35
Type
journal article
Language
en
Open access
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
Funders
  • National Institute of General Medical Sciences
  • National Institutes of Health (P41 GM103403)
  • NIH-ORIP HEI (S10 RR029205)
  • Argonne National Laboratory (DE-AC02-06CH11357)
  • U.S. Department of Defense (W81XWH-07-0448)
  • NIH (T32GM007287, R01CA103866, AI47389, T32 GM007753, F30 CA189333, F31 CA180271, F31 CA189437)
  • MIT Whitaker Health Sciences Fund
  • Damon Runyon Cancer Research Foundation (DRG-112-12)
  • Department of Defense Breast Cancer Research (BC120208)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
Keywords
Sestrin2, mTORC1, leucine sensing, amino acid sensing, GATOR2, raptors, kinase regulation, crystal structure, cryo-EM structure, cell growth regulation, metabolic control, therapeutic target
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Sestrins, Amino Acid Sequence, Binding Sites, Humans, Leucine, Molecular Sequence Data, Mutation, Nuclear Proteins, Protein Binding, Protein Structure, Secondary, Protein Structure, Tertiary, Crystallography, X-Ray, Multiprotein Complexes, Metabolic Networks and Pathways, HEK293 Cells, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review